Cargando…

Lower‐risk myelodysplastic syndromes: Current treatment options for anemia

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematological disorders. Treatment options are classified and defined by prognostic risk based on the International Prognostic Scoring System (IPSS) and, more recently, the revised IPSS (IPSS‐R). The treatment goal for lower‐risk MD...

Descripción completa

Detalles Bibliográficos
Autores principales: Meunier, Mathieu, Park, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713208/
https://www.ncbi.nlm.nih.gov/pubmed/36467818
http://dx.doi.org/10.1002/jha2.523